Replies to post #749 on Pressure Biosciences Inc (PBIO)

[namtae]

Here's what Im referring to

Let's say the PBIO offering gets priced at $4.50 (the equivalent of .15 pre split) and its possible. Much of the convertible preferred and/or debt, warrants etc, some of which convert at .28 (or $7.80 post split), will be adjusted down to the new pricing.

For example, the appx $6m PBIO raised in debt or preferred (cant recall) which convert at .28 into appx 21m shares, would now convert at .15 or 40,000,000 shares. This adds an additional 19m shares, on top the of 21m shs it was already convertible into before the offering gets priced.

Split adjusted, it takes the appx 1m shares outstanding today up to 2.3m shares and thats before looking into other convertible securities, warrants etc that PBIO has outstanding with similar provisions

Then add in the shares included in the offering